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Curli fibrils are proteinaceous bacterial structures
formed by amyloid fibrils composed of the major curli
subunit CsgA. Like b-amyloid 1–42, which is asso-
ciated with brain inflammation and Alzheimer’s
disease, curli fibrils have been implicated in the
induction of host inflammatory responses. However,
the underlying mechanisms of amyloid-induced
inflammation are not fully understood. In a mouse
sepsis model, we show that curli fibrils contributed
to Nos2 expression, a hallmark of inflammation, by
stimulating Toll-like receptor (TLR) 2. The TLR2
agonist activity was reduced by an amyloidogenic-
ity-lowering amino acid substitution (N122A) in
CsgA. Amyloid-forming synthetic peptides corre-
sponding to b-amyloid 1–42 or CsgA 111–151 stimu-
latedNos2 production in macrophages and microglia
cells through a TLR2-dependent mechanism. This
activity was abrogated when an N122A substitution
was introduced into the synthetic CsgA peptide.
The induction of TLR2-mediated responses by bacte-
rial and eukaryotic amyloids may explain the inflam-
mation associated with amyloids and the resulting
pathologies.
INTRODUCTION
Amyloids, named after their amylose-like ability to stain with
iodine, are fibrils composed of orderly repeats of protein with
a b sheet structure, in which the b sheets are oriented perpen-
dicular to the fibrillar axis (Otzen and Nielsen, 2007). The forma-
tion of amyloids by human proteins characterizes several
illnesses, including Alzheimer’s disease, Huntington’s disease,
type 2 diabetes, secondary amyloidosis, and prion diseases.
The pathogenesis of these conditions involves marked inflam-
mation at sites of amyloid deposition, resulting in tissue injury
(Cherny et al., 2005). However, the mechanisms by which
amyloid deposits elicit inflammatory responses remain poorly
characterized.
The csg gene cluster of Escherichia coli encodes the produc-
tion of curli fibrils (Olse´n et al., 1989), proteinaceous surface
structures mediating biofilm formation and binding of host
proteins. The biogenesis of curli on the bacterial cell surface
involves formation of amyloid fibrils composed of the majorsubunit CsgA. Unlike formation of eukaryotic amyloids, curli
formation requires a specific assembly machinery, including
nucleator proteins (CsgB and CsgF) that initiate the polymeriza-
tion of secreted CsgA subunits into fibrils (Chapman et al., 2002).
Studies on the pathogenesis of E. coli and S. enterica infec-
tions have implicated curli fibrils in the induction of inflammatory
responses. Curli fibrils elicit IL-8 expression in macrophages and
contribute to the development of hypotension and increased
plasma nitrite/nitrate levels in a mouse model of E. coli sepsis
(Bian et al., 2000, 2001). Deletion of csgBA in the closely related
pathogen S. enterica serotype Typhimurium reduces its ability to
elicit intestinal inflammation in a calf model (Tu¨kel et al., 2005).
Studies on the CsgA curlin subunit suggest that the generation
of these host responses involves the stimulation of Toll-like
receptor (TLR) 2 signaling by curli fibrils (Tu¨kel et al., 2005).
The identification of CsgA as a pathogen-associated molecular
pattern (PAMP) that signals through TLR2 is somewhat
surprising, because the csg gene cluster is only present in a
small number of closely related genera belonging to the family
Enterobacteriaceae, including Salmonella, Shigella, Escherichia,
Citrobacter, Enterobacter, and Klebsiella (Zogaj et al., 2003). In
contrast, other PAMPs of gram-negative bacteria, such as lipo-
polysaccharide (LPS) or flagellin, are widely conserved among
members of the phylum Proteobacteria. To better understand
which properties make curli fibrils a logical target for recognition
of conserved molecular patterns by the innate immune system,
we studied the mechanism by which this bacterial product is
recognized by TLR2.
RESULTS
The S. Typhimurium csg Operon Contributes
to Nos2 Expression In Vivo
The E. coli csg operon has recently been implicated in contri-
buting to an elevated expression of the inducible nitric oxide syn-
thase gene (Nos2) in amouse shockmodel (Bian et al., 2001).We
investigatedwhether TLR2 stimulation by curli fibrils is themech-
anism responsible this increased Nos2 expression. S. Typhimu-
rium bacteremia was modeled using intraperitoneal infection of
C57BL/6 mice to synchronize the arrival of bacteria at systemic
sites of infection. To establish the relevance of curli fibrils in
inducing inflammatory responses in this model, we investigated
host responses in C57BL/6 mice infected intraperitoneally with
the curli producing S. Typhimurium wild-type (IR715) or a strain
deficient for curli production (csgBAmutant, SF15). As a control,
mice were either mock infected or inoculated with an S. Typhi-
murium msbB mutant (RPW3). A mutation in msbB reduces theCell Host & Microbe 6, 45–53, July 23, 2009 ª2009 Elsevier Inc. 45
Cell Host & Microbe
Amyloids Are Recognized by TLR2acylation of lipid A, which abrogates the ability of LPS to function
as a TLR4 agonist (Somerville et al., 1996). Compared to mock-
infected animals, expression of Nos2 was induced more than
4000-fold in the liver of mice 8 hr after S. Typhimurium infection
(Figure 1). In contrast, Nos2mRNA levels were markedly blunted
in wild-type mice infected with themsbBmutant, confirming the
importance of LPS for inducing host responses (Khan et al.,
1998).Nos2 levels were alsomarkedly reduced in TLR2-deficient
(TLR2/) mice infected with the S. Typhimurium wild-type, sug-
gesting that both TLR2 and TLR4 are necessary for fully inducing
this response in vivo. Importantly, the level of Nos2 mRNA was
significantly (p = 0.006) lower in mice infected with a strain defi-
cient for curli production (csgBA mutant) than in mice infected
with the curli producing S. Typhimurium wild-type. In contrast,
the curli producing S. Typhimurium wild-type and a strain defi-
cient for curli production (csgBA mutant) elicited similar Nos2
mRNA levels when the experiment was repeated with TLR2/
mice (Figure 1A). These data provided genetic evidence for
a contribution of curli fibrils to the induction Nos2 expression
in vivo. Deletion of csgBA did not reduce Nos2 expression to
the same degree as TLR2 deficiency, suggesting that curli coop-
erates with other TLR2 ligands (e.g., lipoprotein) to fully induce
nitric oxide synthase (iNOS) production in vivo.
TLR2 Stimulation by Curli Fibrils Contributes
to iNOS Production
The induction of host responses during bacteremia results from
the initial interactions of bacteria with tissue macrophages and/
or blood monocytes through bacterial-specific TLRs (Cristofaro
and Opal, 2003; Weighardt and Holzmann, 2007). To study the
mechanism by which curli fibrils contribute to host responses
during bacteremia, we investigated whether these surface struc-
tures were able to stimulate bone marrow-derived macrophages
(BMDMs) isolated from C57BL/6 mice to produce iNOS. The
compound produced by iNOS is nitric oxide, a product that is
labile in the presence of oxygen. Nitrite, the major byproduct of
nitric oxide upon reaction with oxygen, was detected after stimu-
lation of BMDMs using the Griess assay. Native curli fibrils were
gel purified from the S. Typhimurium msbB mutant to avoid
contamination with LPS. Stimulation of BMDMs with increasing
concentrations of curli fibrils did not result in increased nitrite
production (Figure 1B). However, when the same assay was per-
formed in thepresenceof IFNg, a cytokinepresent inbloodduring
sepsis, stimulation of BMDMs with increasing concentrations of
curli fibrils resulted in increased nitrate production. These data
suggested that iNOS production in BMDMs was induced syner-
gistically by IFNg and curli. We hypothesized that TLR2 stimula-
tion may be a potential mechanism by which curli fibrils may
contribute to iNOS production in BMDMs. To test this idea, nitrite
production induced by curli fibrils in IFNg-stimulated BMDMs
from control mice (C57BL/6) was compared to that in IFNg-stim-
ulated BMDMs from TLR2/ mice. TLR2 deficiency abrogated
the ability of curli to induce iNOS production in IFNg-stimulated
BMDMs. Similarly, synthetic lipopeptide (Pam3CSK4), a well-
characterizedTLR2agonist (Aliprantis et al., 1999), inducednitrite
production in IFNg-stimulated BMDMs from wild-type mice but
not from TLR2/mice (Figure 1C). Collectively, these data sug-
gested that native curli fibrils contributed to iNOS production
during bacteremia by stimulating macrophages through TLR2.46 Cell Host & Microbe 6, 45–53, July 23, 2009 ª2009 Elsevier Inc.A N122A Substitution Reduces the TLR2 Agonist
Activity of S. Typhimurium CsgA
To characterize the interaction of curli fibrils with TLR2 in more
mechanistic detail, we initially reduced the complexity of our
experimental model. To this end, we investigated stimulation of
human kidney (HEK293) cells stably transfected with human
TLR2 and the CD14 adaptor protein (HEK293-TLR2CD14 cells)
with purified recombinant CsgA, the major subunit of curli
fibrils. HEK293-TLR2CD14 cells were stimulated with increasing
Figure 1. Contribution of Curli Fibrils to iNOS Production during
S. Typhimurium Sepsis
(A) Nos2 mRNA levels observed in the liver of mice 8 hr after intraperitoneal
infection of wild-type mice or TLR2/ mice with 108 cfu of S. Typhimurium
(wild-type), a csgBA mutant, or a msbB mutant. Each bar represents the
average fold increases in Nos2 expression of S. Typhimurium-infected mice
(n = 4) compared to mock-infected mice (n = 4) ± SEM. Statistical significance
of differences is indicated by a bracket. NS, not significantly different.
(B) Nitrite production by BMDMs fromC57BL/6mice in response to stimulation
with increasing concentrations of purified curli fibrils in the presence (closed
circles) or absence (open circles) of IFNg (200 units/ml). Data represent aver-
ages ± SEM from at least three independent experiments.
(C) Nitrite production by IFNg-treated BMDMs from C57BL/6 mice (closed
circles) or TLR2/mice (open circles) after stimulation with purified curli fibrils
or synthetic lipopeptide (Pam3CSK4). Data represent averages ± SEM from at
least three independent experiments.
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Agonist Activity of CsgA
Production of IL-8 was determined 24 hr after
stimulation of HEK293-TLR2CD14 cells with
different affinity-purified fusion proteins or syn-
thetic peptides (Pam3CSK4) using ELISA. Data
are shown as averages ± SEM from at least three
independent experiments. Stimulation with in-
creasing concentrations of synthetic lipopeptide
(Pam3CSK4), GST, or GST-CsgA protein is shown
in (A). Stars indicate that IL-8 production was
significantly (p < 0.05) increased compared to
stimulation with GST control. Stimulation with
affinity-purified fusion proteins between GST and
truncated forms of CsgA (0.15 mM) is shown in
(B). Brackets and P values indicate results from
statistical analysis.concentrations of purified glutathione S-transferase (GST)
protein (negative control), GST-CsgA fusion protein (Humphries
et al., 2003), or Pam3CSK4 (positive control) (Figure 2). Measure-
ments of IL-8 production were used to follow stimulation,
because TLR2-dependent production of this cytokine does not
require IFNg. Pam3CSK4 and GST-CsgA elicited IL-8 secretion
by HEK293-TLR2CD14 cells, while no stimulation was observed
with GST protein (Figure 2A). Neither ligand elicited IL-8 produc-
tion in HEK293 cells (data not shown). Our data suggested that
the GST-CsgA fusion protein was a potent TLR2 agonist,
although its activity appeared to be lower than that of Pam3CSK4.
To identify regions within CsgA contributing to TLR2 stimulation,
we constructed GST fusion proteins containing the 22-residue
N-terminal domain of mature CsgA (residues 21–42 in the
CsgA primary sequence, GST-CsgA-N), or the amyloidogenic
C-terminal domain, which contains 5 conserved repeat regions(residues 43–151, GST-CsgA-R1-5) (Collinson et al., 1999).
Only a fusion protein containing the C-terminal domain elicited
IL-8 production in HEK293-TLR2CD14 cells at levels similar to
GST-CsgA (Figure 2B). Next, we constructed GST fusions
containing the R1 repeat (GST-CsgA-R1), the R1–R3 repeats
(GST-CsgA-R1-3) or the R4-R5 repeats (GST-CsgA-R4-5). Only
GST-CsgA-R4-5 elicited IL-8 production in HEK293-TLR2CD14
cells, although at reduced levels compared to GST-CsgA
(Figure 2B). These data suggested that the R4-R5 repeat region
is necessary and sufficient for eliciting IL-8 production through
TLR2.
To determine whether residues conserved among different
bacterial pathogens are important for TLR2 stimulation, we con-
structed GST fusions to CsgA proteins from both E. coli and
Shigella sonnei (Figure 3). Purified fusion proteins containing
CsgA from E. coli or S. sonnei elicited similar levels of IL-8Figure 3. Identification of CsgA Residues
Required for Its TLR2 Agonist Activity
(A) Stimulation with GST-CsgA fusion proteins
(0.15 mM) from S. Typhimurium, E. coli, and S. son-
nei. ns, not significant.
(B) Primary sequence of the amyloidogenic
C-terminal domain of S. Typhimurium CsgA (resi-
dues 43–151), which contains 5 repeat regions
(R1–R5). A gray background indicates residues
that are conserved between CsgA proteins from
different members of the Enterobacteriaceae. A
dark gray background indicates residues that
were subjected to alanine scanning mutagenesis.
A box indicates the amyloidogenic QYGGNN
hexapeptide.
(C) Stimulation with affinity-purified GST-CsgA-
R1-5 fusion proteins (0.15 mM) carrying the indi-
cated amino acid substitutions. Brackets and
P values indicate results from statistical analysis.
Production of IL-8 was determined 24 hr after
stimulation of HEK293-TLR2CD14 cells with
different affinity-purified fusion proteins using
ELISA. Data are shown as averages ± SEM from
at least three independent experiments.Cell Host & Microbe 6, 45–53, July 23, 2009 ª2009 Elsevier Inc. 47
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S. Typhimurium (Figure 3A). These data suggested that residues
important for TLR2 recognition are conserved between CsgA
proteins from different genera. Conserved amino acid residues
within the R4-R5 repeat region (Figure 3B) were replaced in
GST-CsgA-R1-5 by alanine residues using site-directed muta-
genesis. Of 14 fusion proteins containing alanine substitutions
of conserved amino acid residues, 6 did not form stable proteins
and could not be purified (data not shown). The remaining 8
fusion proteins were purified and tested for their ability to elicit
IL-8 production in HEK293-TLR2CD14 cells. Only one fusion
protein, containing amino acid substitution N122A (GST-CsgA-
R1-5N122A), exhibited a greatly attenuated ability to stimulate
IL-8 secretion compared to GST-CsgA-R1-5 (Figure 3C). Inter-
estingly, the asparagine residue 122 is located in a region of
the protein whose corresponding region in E. coli CsgA forms
amyloid fibrils when produced as a synthetic hexapeptide
(Cherny et al., 2005).
The Ability of CsgA to Form Amyloids Is Required
for Signaling through TLR2
In the absence of the CsgB and CsgF nucleator proteins, CsgA
adopts a soluble form that, upon prolonged incubation, assem-
bles into curli amyloid fibrils (Chapman et al., 2002). To investi-
gate whether the N122A substitution affected amyloid formation
of S. Typhimurium CsgA, increasing concentrations of purified
fusion proteins were incubated with the amyloid-specific dye
Thioflavin T (ThT) (LeVine, 1993; Wang et al., 2007) (Figure 4).
GST-CsgA-R1-5 exhibited significantly greater ThT fluorescence
than GST-CsgA-R1-5N122A, indicating that the N122A substitu-
tion reduced amyloid formation (Figure 4A). Analysis of the
protein secondary structure with circular dichroism (CD) spec-
troscopy revealed that GST-CsgA-R1-5 produced a peak at
approximately 197 nm and a trough at approximately 220 nm,
which is characteristic of proteins containing predominantly
b sheet structure (CD spectroscopy predicted 95% b sheet
structure). In contrast, GST-CsgA-R1-5N122A failed to show
these features in the CD spectrum (Figure 4B), suggesting that
this protein had much less secondary structure (CD spectros-
copy predicted 25% b sheet structure). These biochemical
features were consistent with the idea that the N122A substitu-
tion reduced amyloidogenicity. The reduced ThT binding and
altered CD spectrum correlated well with a reduced ability of
GST-Csg-A-R1-5N122A to elicit IL-8 secretion in HEK293-
TLR2CD14 cells (Figure 4C). Collectively, these data suggested
that the TLR2 agonist activity of CsgA was related to its ability to
form amyloids.
Glutamine-/asparagine-rich domains of proteins have a high
propensity to assemble amyloid fibrils (Michelitsch and Weiss-
man, 2000) by forming b sheets linked together by hydrogen
bonds (Perutz et al., 2002). The C-terminal amyloid domain of
CsgA consists of 5 imperfect direct repeats of 19–23 amino acids
(R1–R5), each containing a hexapeptide with conserved gluta-
mine and asparagine residues (Barnhart and Chapman, 2006)
and a chemical composition similar to prion protein repeats
(Cherny et al., 2005). A role of E. coli CsgA hexapeptide
sequences in amyloid formation is suggested by the finding
that the corresponding synthetic peptides form amyloid fibrils
(Cherny et al., 2005; Wang et al., 2007). We further investigated48 Cell Host & Microbe 6, 45–53, July 23, 2009 ª2009 Elsevier Inc.the effect of an N122A substitution on amyloid formation by elec-
tron microscopic examination of synthetic S. Typhimurium CsgA
hexapeptides (Figure 5).E. coliCsgA contains the amyloidogenic
hexapeptide QFGGGN (residues 117–122), which can form
amyloid fibrils (Cherny et al., 2005). The N122A substitution
was located in the corresponding hexapeptide QYGGNN (resi-
dues 117–122) of the S. Typhimurium CsgA protein (Figure 3B).
A positive control (b-amyloid 1–40 peptide) and the synthetic
peptides QYGGNN and QYGGNA (corresponding to an N122A
substitution) were incubated at 37C for 7 days to promote
amyloid fibril formation. Synthetic b-amyloid 1–40 and the
Figure 4. Effect of an N122A Substitution on the Ability of Affinity
Purified GST-CsgA-R1-5 to Form Amyloids and Serve as TLR2
Agonist
(A) Increasing concentrations of GST-CsgA-R1-5 and GST-CsgA-R1-5N122A
fusion proteins were stained with the amyloid-specific dye Thioflavin T (ThT),
and fluorescence was measured (438 nm excitation, 495 nm emission). Data
are shown as averages ± SEM from three independent experiments. Stars indi-
cate that ThT fluorescence of GST-CsgA-R1-5 was significantly (p < 0.05)
increased compared to GST-CsgA-R1-5N122A.
(B) Analysis of the far ultraviolet spectrum (from 190 to 260 nm) of GST-CsgA-
R1-5 and GST-CsgA-R1-5N122A by CD spectroscopy.
(C) Stimulation of HEK293-TLR2CD14 cells with increasing concentrations of
GST-CsgA-R1-5 and GST-CsgA-R1-5N122A. Production of IL-8 was deter-
mined 24 hr later using ELISA. Data are shown as averages ± SEM from three
independent experiments. Brackets and P values indicate results from statis-
tical analysis.
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the CsgA QYGGNN Hexapeptide
(A–C) Formation of amyloid fibrils by synthetic
QYGGNN hexapeptide (A), synthetic QYGGNA
hexapeptide (B), and synthetic b-amyloid 1–40
peptide from amyloid plaques of Alzheimer’s
disease (C) was investigated by negative staining
and visualized by electron microscopy.QYGGNN peptide formed fibrils, while the QYGGNA peptide did
not (Figure 5).
Responses to Amyloids of Host and Microbial Origin
Are Mediated through TLR2
To investigate whether responses to amyloids of both host and
microbial origin are mediated through TLR2, human macro-
phage-like (THP-1) cells were stimulated with purified curli fibrils
or b-amyloid 1–40, and induction of IL-8mRNA was followed by
quantitative real-time PCR analysis (Figure 6). Stimulation of
THP-1 cells with curli fibrils or b-amyloid 1–40 resulted inmarked
induction of IL-8 mRNA expression, which could be partially
inhibited by preincubation with a blocking anti-TLR2 monoclonal
antibody (Figure 6A). These data supported the idea that both
microbial (curli) and host (b-amyloid 1–40) amyloids contribute
to inflammatory cytokine production by stimulating human TLR2.
IFNg and host amyloids are thought to contribute to neurotox-
icity during Alzheimer’s disease by eliciting the production of
reactive nitrogen species (Meda et al., 1995).We therefore deter-
mined whether, similar to curli fibrils (Figure 1), host amyloids
would elicitNos2 expression in IFNg-stimulatedmurine BMDMs.
Purified curli fibrils, synthetic b-amyloid 1–40, and synthetic
b-amyloid 1–42 induced significantly (p < 0.05) higher levels ofNos2 mRNA in IFNg-stimulated BMDMs than IFNg alone. In
contrast, stimulation with a peptide consisting of a scrambled
amino acid sequence of b-amyloid 1–42 (scrambled b-amyloid
1–42) did not induce Nos2 expression above background levels.
Expression of Nos2 elicited in BMDMs upon stimulation with
amyloids was TLR2 dependent, since this response was abro-
gated in BMDMs from TLR2/ mice.
To stringently test whether curli fibrils stimulate host responses
because CsgA has an intrinsic TLR2-agonist activity, it was
necessary to rule out the possibility that preparations used for
stimulation of host cells were contaminated with other bacterial
PAMPs. To this end, we synthesized synthetic peptides
corresponding to the R4-R5 repeats of CsgA (CsgA-R4-5) and
CsgAN122A (CsgA-R4-5N122A). Synthetic peptides were incubated
with ThT tomonitor amyloid formation (Figure 7). As expected, the
positive control (b-amyloid 1–42) exhibited greater ThT fluores-
cence than the negative control peptide (scrambled b-amyloid
1–42).CsgA-R4-5exhibitedsignificantlygreaterThTfluorescence
than CsgA-R4-5N122A, indicating that the N122A substitution
reduced amyloid formation (Figure 7A). The biological activity of
synthetic peptides was investigated using BV2 murine microglia
cells, a cell type relevant for the generation of host responses to
b-amyloid 1–42 in the brain. Expression of TLR2 on the surfaceFigure 6. Proinflammatory Responses Elicited by Amyloids of Bacterial and Host Origin in Macrophages
(A) Stimulation (4 hr) of human THP-1 cells with purified curli fibrils or b-amyloid 1–40 in the presence (open bars) or absence (gray bars) of inhibitory anti-TLR2
monoclonal antibody. Data are shown as average fold increases over nonstimulated THP-1 cells ± SEM from three independent experiments.
(B) Stimulation (4 hr) of murine BMDMs from control mice (C57BL/6, gray bars) or TLR2-deficient mice (TLR2/, open bars) with IFNg and purified curli fibrils
(1 mg/ml) or synthetic peptides (b-amyloid 1–40, b-amyloid 1–42, or scrambled b-amyloid 1–42; 20 mM). Data are shown as average fold increases in mRNA levels
over those detected in nonstimulated BMDMs (i.e., in cells not stimulated with IFNg or amyloids) ± SEM from three independent experiments.Cell Host & Microbe 6, 45–53, July 23, 2009 ª2009 Elsevier Inc. 49
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Microglia cells were treated with IFNg and stimulated with
synthetic peptides. Pam3CSK4 induced Nos2 expression in
microglia cells at levels similar to synthetic b-amyloid 1–42 and
synthetic CsgA-R4-5. In contrast, scrambled b-amyloid 1–42
andCsgA-R4-5N122Adidnot induceNos2expressionaboveback-
ground levels. Induction of Nos2 expression by Pam3CSK4,
b-amyloid 1–42, or CsgA-R4-5 could be inhibited by preincuba-
tionofmicroglia cellswith ablocking antimurineTLR2monoclonal
antibody (Figure 7C). Collectively, these data demonstrated that
responses to both host (b-amyloid 1–42) and microbial (CsgA)
amyloids are mediated through TLR2.
DISCUSSION
Amyloid formation in the host is thought to result from pathologic
conditions leading to protein misfolding. In contrast, the csgBA
and csgDEFG operons of E. coli and S. Typhimurium encode
nucleation-precipitation machinery specifically dedicated to the
assembly of curli amyloid fibrils (Chapman et al., 2002). Thus,
formation of curli fibrils is the desired outcome rather than the
result of a misguided protein-folding pathway, a difference rele-
vant for in vivo assembly. While specific pathologic conditions
resulting in host amyloid deposition in vivo are a critical factor
in the pathogenesis of amyloidosis, the nucleation-precipitation
machinery assembles curli fibrils independently of specific
environmental factors (Hammer et al., 2007). Conversely, host
proteins involved in the pathogenesis of amyloidosis are soluble
under physiologic condition, but release of soluble CsgA
occurs only in bacteria with defective nucleation-precipitation
Figure 7. Amyloidogenicity and TLR2
Agonist Activity of Synthetic Peptides
(A) Synthetic peptides were stained with the
amyloid-specific dye Thioflavin T (ThT), and fluo-
rescence was measured (438 nm excitation,
495 nm emission) to assess their amyloidogenic-
ity. Data are shown as averages ± SEM from three
independent experiments. Statistical significance
of differences is indicated by a bracket.
(B) Expression of TLR2 on the surface of murine
microglia cells detected by flow cytometry using
anti-TLR2 antibody (anti-TLR2-FITC) or an isotype
control (mIgG-FITC).
(C) Nos2 expression in murine microglia cells that
were either untreated (gray bars) or treated with
anti-TLR2 antibody (open bars). Microglia cells
were stimulated with IFNg (200 units/ml) and
synthetic peptides (CsgA-R4-5, CsgA-R4-5N122A,
b-amyloid 1–42, scrambled b-amyloid 1–42, or
Pam3CSK4, each at a concentration of 10 mM).
Data are shown as averages of fold increases in
Nos2 expression over nonstimulated microglia
cells ± SEM from three independent experiments.
Statistical significance of differences is indicated
by a bracket. NS, not significant.
machinery (e.g., a csgB mutant)
(Chapman et al., 2002). Prolonged incu-
bation of synthetic CsgA peptides re-
sulted in formation of amyloid fibrils,
thereby eliciting host responses through TLR2. The use of
synthetic peptides excluded contamination with other TLR
ligands as a possible explanation for the observed host
responses. However, assembly of CsgA peptides into amyloid
fibrils is not a good model for curli biogenesis in vivo, which
requires the nucleator protein CsgB. The presence of an intact
curli nucleation-precipitation machinery was associated with
significantly increasedNos2mRNA levels duringS. Typhimurium
bacteremia, therebyprovidinggenetic evidence that curli biogen-
esis contributed to host responses in vivo.
Our finding that the CsgA protein stimulates TLR2 signaling
because it forms amyloid fibrils has several important implica-
tions. First, although the csg operon is only present in a small
number of genera within the family Enterobacteriaceae, extracel-
lular amyloid adhesins are widely distributed among several
bacterial phyla, including the Proteobacteria (Alpha-, Beta-,
Gamma-, and Deltaproteobacteria), Bacteriodetes, Chloroflexi,
and Actinobacteria (Larsen et al., 2007). Thus, sensing the pres-
ence of bacterial amyloids through TLR2 may provide the host’s
innate immune system the capacity to detect a large group of
microbes by conserved pattern recognition. Second, amyloid
formation underlies several common human chronic diseases,
and TLR2-mediated recognition may provide a linchpin of
pathogenesis.
For example, amyloidosis is the hallmark of Alzheimer’s
disease, Huntington’s disease, type 2 diabetes, secondary
amyloidosis, and prion diseases, conditions marked by inflam-
mation at sites of amyloid deposition (Cherny et al., 2005).
Alzheimer’s disease is characterized by the presence in the brain
of extracellular plaques consisting of compacted b-amyloid fibril50 Cell Host & Microbe 6, 45–53, July 23, 2009 ª2009 Elsevier Inc.
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macrophage-like cell type in the central nervous system, these
b-amyloid deposits elicit foci of local inflammatory reactions
that contribute to neuronal injury (Akiyama et al., 2000; Town
et al., 2005). Recently, innate immune receptors including TLR2
and CD14 have been implicated in neurodegeneration during
Alzheimer’s disease (Fassbender et al., 2004; Jana et al., 2008;
Letiembre et al., 2007; Richard et al., 2008; Udan et al., 2008)
and in responses to acute-phase serum protein A (Cheng et al.,
2008; He et al., 2009). CD14 directly binds b-amyloid and
increases its uptake by microglia cells (Liu et al., 2005), while
TLR2 triggers an inflammatory response to aggregated
b-amyloid in THP-1 macrophage-like cells (Udan et al., 2008).
Similarly, TLR2 contributed to cytokine production elicited by
curli fibrils and b-amyloid in THP-1 macrophage-like cells.
CsgA elicits IL-8 production in HEK293 cells transfected with
TLR2, but cytokine production is increased further when cells
are transfected with TLR2 and CD14 (Tu¨kel et al., 2005). Here,
we show that cytokine production elicited by CsgA was depen-
dent on the ability of this protein to form amyloid fibrils. Collec-
tively, these data suggest that pattern recognition of amyloid
fibrils of both bacterial and host origin underlies critical triggering
of the innate immune system.
Activation of microglia cells is suggested to contribute to
progressive neuronal injury by the release of neurotoxic pro-
ducts, such as nitric oxide (Hu et al., 1997; Meda et al., 1995).
The induction of iNOS in microglia cultures stimulated with
b-amyloid requires the presence of augmenting factors such as
IFNg or LPS (Goodwin et al., 1995; Meda et al., 1995; Nakamura
et al., 1999). Similarly, we found that Nos2 expression in murine
BMDMs and microglia cells was induced synergistically by
b-amyloid and IFNg. Importantly, our data provided evidence
that the mechanism for inducing Nos2 expression involved
recognition of amyloids by TLR2. This observation has implica-
tions for the pathogenesis of bacterial infections and of amyloid-
associated diseases. For instance, our data suggest that curli
fibrils may contribute to sepsis, because TLR2 stimulation
contributes to the production of nitric oxide, a potent vasodilator
(Kilbourn et al., 1990; Petros et al., 1991). Consistent with this
idea, curli fibrils of E. coli have been shown to contribute to the
development of hypotension and to increased plasma nitrite/
nitrate levels in a mouse sepsis model (Bian et al., 2000, 2001).
Furthermore, our data point to amyloid stimulation of TLR2 as
a potential mechanism contributing to neuronal injury during




S. Typhimurium strain IR715 is a fully virulent, spontaneous nalidixic acid-
resistant derivative of strain ATCC14028 (Stojiljkovic et al., 1995). RPW3 and
SF15 are derivatives of strain IR715 carrying mutations in msbB and csgBA,
respectively (Raffatellu et al., 2005; Weening et al., 2005).
GST Fusion Proteins and Synthetic Peptides
A plasmid pSW5-50 encoding GST-CsgA has been described previously
(Humphries et al., 2003). E. coli and S. sonnei csgA and truncated forms of
S. Typhimurium csgA were amplified using the primer pairs listed in
Table S1 and cloned into PCR2.1 (Invitrogen). GST fusion proteins were con-structed in pGEX-4T-2 and affinity purified as described previously (Humph-
ries et al., 2003). The protein concentration in each sample was determined
by Bradford assay (Ausubel et al., 1994).
Synthetic b-amyloid 1–40-HCl and b-amyloid 1–42 and scrambled b-amyloid
1–42 were purchased from Anaspec (San Jose, CA). Synthetic lipopeptide
(Pam3CSK4) was purchased from InvivoGen. Synthetic peptides CsgAR4-5,
CsgA-R4-5N122A, QYGGNN, and QYGGNA were chemically synthesized by
Biosynthesis (Lewisville, TX).
Site-Directed Mutagenesis
Mutations resulting in single amino acid substitutions were introduced into
csgA using the primer pairs listed in Table S1 using the QuikChange Site-
Directed Mutagenesis Kit (Stratagene; La Jolla, CA).
Tissue Culture
To isolate BMDMs from C57BL/6 mice or TLR2/mice (Takeuchi et al., 1999)
(JacksonLaboratory), femurswere removedandflushedwithcompletemedium
(DMEM, 10% FBS, 2 mM glutamine, 100 mg/ml penicillin, and 100 mg/ml
streptomycin). The bone marrow was then cultured for 3 days in complete
medium supplemented with L cell-conditioned medium, which was prepared
as described (Rola´n and Tsolis, 2007). On day 3, the media were replaced
with fresh complete medium supplemented with L cell-conditioned medium.
On day 7, adherent cells were treated with Trypsin-EDTA (GIBCO, Invitrogen),
and the resulting cell suspension was centrifuged at 1000 rpm for 10 min. The
cells were seeded in 24-well plates at a density of 5 3 105 cells per well. Cells
were then incubated overnight in complete media without L cell-conditioned
media or antibiotics. Curli fibrils were purified from the S. Typhimurium msbB
mutant as described previously (Tu¨kel et al., 2005). A blocking anti-human
TLR2 monoclonal antibody (TL2.1) was purchased from eBioscience (San
Diego, CA) and added to cells at 10 mg/well in 500 ml 1 hr prior to stimulation.
Recombinant mouse IFNg was purchased from eBioscience and added to
BMDMs (100 units/well in 500 ml). Supernatants from stimulated BMDMs were
collected24hrafter stimulationandanalyzed for nitrite productionby incubating
them with an equal volume of Griess reagents (Sigma). Absorbance was
measured at 550 nm to determine nitrite concentration. For real-time PCR
analysis, BMDMs were collected 4 hr after stimulation, and RNA was isolated
with TRI Reagent (Molecular Research Center; Cincinnati) according to the
instruction of the manufacturer. Real-time PCR was performed as described
below (see Animal Experiments).
HEK293 cells stably transfected with human TLR2/CD14 (InvivoGen) were
cultured according to manufacturer’s instructions. Appropriate ligands were
added to HEK293-TLR2CD14 cells, and supernatants were harvested at
24 hr after to determine IL-8 production by ELISA (BioLegend; San Diego, CA).
THP-1 cells were seeded at approximately 5 3 105 cells/well in 24-well
plates containing RPMI1640 + 10% FCS. The cells were differentiated with
50 ng/ml phorbol 12-myristate 13-acetate (PMA) for 48 hr followed by growth
without PMA for 4 days. THP-1 cells were incubated for 1 hr with mouse anti-
human TLR2 antibody (eBioscience, 10 mg/well in 500 ml) or with medium
(control), followed by incubation with b-amyloid 1–40 (20 mM) or curli fibrils
(1 mg/ml) for 4 hr. RNA was extracted to determine IL-8 mRNA levels by real-
time PCR as described previously (Tu¨kel et al., 2005).
BV-2 microglia cells were a kind gift of Dr. Lee-Way Jin (MIND Institute,
University of California, Davis). BV-2 microglia were seeded at approximately
5 3 105 cells/well in 24-well plates containing DMEM + 10% FCS and incu-
bated overnight. Microglia were treated with anti-mouse/-human TLR2 anti-
body (clone T2.5 [eBioscience], 10 mg/well in 500 ml) or with medium (control)
for 1 hr. CsgA-R4-5 (10 mM), CsgA-R4-5N122A (10 mM), b-amyloid 1–42 (10 mM),
scrambled b-amyloid 1–42 (10 mM), Pam3CSK4 (10 mM), and recombinant
mouse IFNg (100 units/well in 500 ml) were added to the wells for 4 hr. RNA
was extracted to determine iNOSmRNA levels by real-time PCR as described
above.
ThT Assay
CsgA samples were incubated for 3 days at 37C and then mixed with 10 mM
ThT (Sigma) 1:1 at a final volume of 200 ml. Fluorescence was measured at
438 nm excitation, 495 nm emission, and 475 nm cutoff settings using a
SpectraMax M2 plate reader (Molecular Devices; Sunnydale, CA).Cell Host & Microbe 6, 45–53, July 23, 2009 ª2009 Elsevier Inc. 51
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Samples of purified GST-CsgA-R1-5 GST-CsgA-R1-5N122A fusion protein
(0.7 mg/ml) were analyzed in a Jasco J-715 (Tokyo, Japan) spectropolarimeter
from 190 to 260 nm in a quartz cell at RT.
Peptide Preparation and Electron Microscopy
A volume of 10 ml of each samplewas loaded on a Formvar-coated copper grid,
incubated for 2 min, and negatively stained with 2% uranyl acetate for 20 s.
Flow Cytometry
Microglia cell suspensions containing 5 3 105 cells were washed once with
FACS buffer and treated with rat anti-mouse CD16/CD32 (Fc block, BD Biosci-
ences). Cells were then stained for 30 min in the dark at 4C with optimized
concentrations of Alexa Fluor 488-conjugated anti-mouse/-human TLR2 or
IgG1 K isotype control antibodies (eBioscience). Cells were then washed
once and resuspended in FACS buffer and analyzed using an LSR II flow
cytometer (Becton Dickinson; San Jose, CA). The data were analyzed using
FlowJo software (Treestar, Inc.; Ashland, OR).
Animal Experiments
For mouse experiments, 4- to 6-week-old female C57BL/6 mice (Jackson
Laboratory) were used. Groups of four mice were intraperitoneally infected
with 1 3 108 cfu in PBS or sterile PBS (mock infection). At 8 hr after infection,
mice were sacrificed and a sample of the liver was collected from eachmouse.
Liver tissuewas immediately snap-frozen in liquid nitrogenandstoredat80C.
RNA was extracted from snap-frozen tissue with TRI Reagent (Molecular
Research Center) according to the instruction of the manufacturer. One thou-
sand nanograms of RNA from each sample was reverse transcribed in 0.05 ml
volume (TaqMan Reverse Transcription Reagent, Applied Biosystems; Foster
City, CA). cDNA (0.005ml) was used for each real-time reaction. Real-time PCR
was performed using SYBR Green (Applied Biosystems) and the 7900HT Fast
Real-Time PCR System. The data were analyzed using the comparative Ct
method (Applied Biosystems). Fold increases in cytokine expression in infected
mice were calculated relative to the average level of the respective cytokine in
fourmock-infectedmice. Theprimers forGapdhandNos2havebeendescribed
previously (Roux et al., 2007; Wilson et al., 2008).
Statistical Analysis
For statistical analysis of data, fold changes in mRNA levels measured by real-
time PCR underwent logarithmic transformation. Statistical analysis of data
was performed using a Student’s t test.
SUPPLEMENTAL DATA
Supplemental Data include one table and can be found online at http://www.
cell.com/cell-host-microbe/supplemental/S1931-3128(09)00213-3.
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